Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionWest Paces Advisors Inc.
Latest Disclosed Ownership2,169 shares
Latest Disclosed Value $ 302,294
West Paces Advisors Inc. ownership in GILD / Gilead Sciences, Inc.

On May 5, 2026 - West Paces Advisors Inc. filed a 13F-HR form disclosing ownership of 2,169 shares of Gilead Sciences, Inc. (CH:GILD) valued at $302,294 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 2,169 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,169 0 0.00 302 13.53 0.0586
2026-01-21 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,169 152 7.54 266 19.28 0.0515
2025-10-22 2025-09-30 13F GILEAD SCIENCES COM 375558103 2,017 0 0.00 224 0.00 0.0446
2025-07-23 2025-06-30 13F GILEAD SCIENCES COM 375558103 2,017 -230 -10.24 224 -11.16 0.0476
2025-04-15 2025-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 2,247 0 0.00 252 21.26 0.0574
2025-02-14 2024-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 2,247 0 0.00 208 10.11 0.0507
2024-10-15 2024-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 2,247 0 0.00 188 22.08 0.0461
2024-07-17 2024-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 2,247 0 0.00 154 -6.10 0.0402
2024-04-15 2024-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 2,247 -15 -0.66 165 -10.38 0.0434
2024-01-30 2023-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 2,262 15 0.67 183 8.93 0.0515
2023-12-18 2023-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 2,247 0 0.00 168 -2.89 0.0527
2023-12-18 2023-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 2,247 0 0.00 173 -6.99 0.0510
2023-12-18 2023-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 2,247 35 1.58 186 -1.59 0.0579
2023-12-18 2022-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 2,212 0 0.00 190 38.97 0.0604
2023-12-19 2022-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 2,212 0 0.00 136 0.00 0.0485
2023-12-19 2022-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 2,212 0 0.00 137 3.82 0.0465
2023-12-19 2022-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 2,212 0 0.00 132 -18.12 0.0410
2023-12-20 2021-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 2,212 1,152 108.68 161 116.22 0.0501
2023-12-20 2021-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,060 0 0.00 74 2.78 0.0260
2023-12-20 2021-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,060 0 0.00 73 5.88 0.0268
2023-12-20 2021-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,060 0 0.00 69 11.48 0.0275
2023-12-20 2020-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,060 0 0.00 62 -7.58 0.0275
2023-12-20 2020-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,060 0 0.00 67 -18.52 0.0342
2023-12-20 2020-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,060 0 0.00 82 2.53 0.0441
2023-12-21 2020-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,060 -133 -11.15 79 2.60 0.0503
2023-12-22 2019-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,193 0 0.00 78 2.67 0.0422
2023-12-22 2019-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,193 0 0.00 76 -6.25 0.0452
2023-12-22 2019-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,193 0 0.00 81 3.90 0.0503
2023-12-22 2019-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,193 -30 -2.45 78 1.32 0.0543
2023-12-22 2018-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,223 0 0.00 76 -19.15 0.0590
2023-12-21 2018-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,223 0 0.00 94 9.30 0.0680
2023-12-22 2018-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,223 30 2.51 87 -3.37 0.0648
2023-12-22 2018-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,193 0 0.00 90 4.71 0.0669
2023-12-22 2017-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,193 -155 -11.50 85 -22.02 0.0633
2023-12-22 2017-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,348 74 5.81 109 21.11 0.0823
2023-12-22 2017-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,274 -163 -11.34 90 -7.22 0.0716
2023-12-22 2017-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,437 -1,081 -42.93 98 -46.11 0.0778
2023-12-22 2016-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 2,518 2,518 180 0.1683
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.